These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35731254)

  • 1. Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens.
    Choi GH; Holzapfel WH; Todorov SD
    Crit Rev Microbiol; 2023 Sep; 49(5):578-597. PubMed ID: 35731254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriocin-Based Synergetic Consortia: a Promising Strategy to Enhance Antimicrobial Activity and Broaden the Spectrum of Inhibition.
    Soltani S; Biron E; Ben Said L; Subirade M; Fliss I
    Microbiol Spectr; 2022 Feb; 10(1):e0040621. PubMed ID: 35170996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocins from lactic acid bacteria as an alternative to antibiotics.
    Ołdak A; Zielińska D
    Postepy Hig Med Dosw (Online); 2017 May; 71(0):328-338. PubMed ID: 28513457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Peptides Derived from Bacteria: Classification, Sources, and Mechanism of Action against Multidrug-Resistant Bacteria.
    Mihaylova-Garnizova R; Davidova S; Hodzhev Y; Satchanska G
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in bacteriocin application as antimicrobials.
    Gillor O; Ghazaryan L
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):115-22. PubMed ID: 18221167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins.
    Wolska KI; Grześ K; Kurek A
    Pol J Microbiol; 2012; 61(2):95-104. PubMed ID: 23163208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactic acid bacteria and their bacteriocins: new potential weapons in the fight against methicillin-resistant
    Yaacob SN; Wahab RA; Misson M; Sabullah MK; Huyop F; Zin NM
    Future Microbiol; 2022 Jun; 17():683-699. PubMed ID: 35414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gram-positive bacteriocins: usage as antimicrobial agents in veterinary medicine.
    Schofs L; Sparo MD; Sánchez Bruni SF
    Vet Res Commun; 2020 Nov; 44(3-4):89-100. PubMed ID: 32656740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocins from lactic acid bacteria and their potential clinical applications.
    Fernandes A; Jobby R
    Appl Biochem Biotechnol; 2022 Oct; 194(10):4377-4399. PubMed ID: 35290605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocins: Potential for Human Health.
    Huang F; Teng K; Liu Y; Cao Y; Wang T; Ma C; Zhang J; Zhong J
    Oxid Med Cell Longev; 2021; 2021():5518825. PubMed ID: 33936381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.
    Barbosa AAT; de Melo MR; da Silva CMR; Jain S; Dolabella SS
    Crit Rev Microbiol; 2021 May; 47(3):376-385. PubMed ID: 33689548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Features, Mechanisms of Action, and Prospects for Practical Application of Class II Bacteriocins.
    Antoshina DV; Balandin SV; Ovchinnikova TV
    Biochemistry (Mosc); 2022 Nov; 87(11):1387-1403. PubMed ID: 36509729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriocins produced by lactic acid bacteria].
    Bilková A; Sepova HK; Bilka F; Balázová A
    Ceska Slov Farm; 2011 Apr; 60(2):65-72. PubMed ID: 21650008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials.
    Gillor O; Nigro LM; Riley MA
    Curr Pharm Des; 2005; 11(8):1067-75. PubMed ID: 15777256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are bacteriocins underexploited? Novel applications for old antimicrobials.
    Montalbán-López M; Sánchez-Hidalgo M; Valdivia E; Martínez-Bueno M; Maqueda M
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1205-20. PubMed ID: 21470151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica.
    Sharma P; Rashid M; Kaur S
    Microb Cell Fact; 2020 May; 19(1):98. PubMed ID: 32366243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections.
    Ghodhbane H; Elaidi S; Sabatier JM; Achour S; Benhmida J; Regaya I
    Infect Disord Drug Targets; 2015; 15(1):2-12. PubMed ID: 24853876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Action of Antibiotics and Bacteriocins against Vancomycin-Resistant Enterococci.
    Bucheli JEV; Fugaban JII; Holzapfel WH; Todorov SD
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.